Article
CCT6A, a novel prognostic biomarker for Ewing's sarcoma
2020-09-08
Abstract excerpt
<title>Abstract</title> <p>Background Ewing's sarcoma (ES) is the second most prevalent malignancy among bone tissue tumors, and there is no adequate prognosis biomarker. The protein encoded by CCT6A is a molecular chaperone. Early studies have suggested that CCT6A is involved in the development of many cancers, however, there is no clear evidence of a role for CCT6A in ES. Methods In this study, we performed a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a33b814f-d39e-5549-a380-8a35c5f0a79a
- DOI
- 10.21203/rs.3.rs-67702/v1